Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11503441 | 0.86 | CRBN (0.39) | CRBN | |
| SCHEMBL7433419 | 0.69 | HTR2A (0.42) | — | |
| SCHEMBL5963193 | 0.68 | — | — | |
| SCHEMBL21473 | 0.63 | — | — | |
| SCHEMBL2267145 | 0.63 | — | — | |
| SCHEMBL37624 | 0.63 | — | — | |
| SCHEMBL737201 | 0.60 | ITGB3 (0.34) | CRBN | |
| SCHEMBL12308060 | 0.60 | CRBN (0.32) | CRBN | |
| SCHEMBL6271848 | 0.60 | — | — | |
| SCHEMBL3944202 | 0.60 | CRBN (0.32) | CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1465670-A2 | LABELING TARGETING AGENTS WITH GALLIUM-68 AND GALLIUM-67 | Immunomedics, Inc. (US) | 2004-10-13 | — | — | EP | claimed |
| EP-1444267-A2 | AFFINITY ENHANCEMENT AGENTS | Immunomedics, Inc. (US) | 2004-08-11 | — | — | EP | claimed |
| WO-2003059397-A2 | LABELING TARGETING AGENTS WITH GALLIUM-68 AND GALLIUM-67 | IMMUNOMEDICS, INC. (US) | 2003-07-24 | — | — | WO | claimed |
| WO-2003033653-A2 | AFFINITY ENHANCEMENT AGENTS | IMMUNOMEDICS, INC. (US) | 2003-04-24 | — | — | WO | claimed |
| WO-1989004672-A1 | DERIVATIVES OF LINCOSAMINIDE ANTIBIOTICS | THE UPJOHN COMPANY (US) | 1989-06-01 | — | — | WO | claimed |
| EP-2311500-B1 | Labeling targeting agents with gallium-68 and gallium-67 | IMMUNOMEDICS INC (US) | 2015-02-25 | — | — | EP | disclosed |
| EP-2662087-A1 | Somatostatin vectors | IPSEN PHARMA (FR) | 2013-11-13 | — | — | EP | disclosed |
| EP-2311500-A1 | Labeling targeting agents with gallium-68 and gallium-67 | Immunomedics, Inc. (US) | 2011-04-20 | — | — | EP | disclosed |
| EP-2161037-A2 | Camptothecin-Somatostatin conjugates | IPSEN PHARMA (FR) | 2010-03-10 | — | — | EP | disclosed |
| EP-1624884-A4 | SOMATOSTATIN VECTORS | IPSEN PHARMA (FR) | 2009-08-05 | — | — | EP | disclosed |
| EP-1624884-A2 | SOMATOSTATIN VECTORS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) | 2006-02-15 | — | — | EP | disclosed |
| EP-1468097-A4 | METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS | IMMUNOMEDICS INC (US) | 2006-01-11 | — | — | EP | disclosed |
| WO-2004093807-A2 | SOMATOSTATIN VECTORS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) | 2004-11-04 | — | — | WO | disclosed |
| EP-1468097-A2 | METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS | Immunomedics Inc. (US) | 2004-10-20 | — | — | EP | disclosed |
| EP-1444267-A2 | AFFINITY ENHANCEMENT AGENTS | Immunomedics, Inc. (US) | 2004-08-11 | — | — | EP | disclosed |
| WO-2003057829-A2 | METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM VH AND VL DOMAINS | IMMUNOMEDICS, INC. (US) | 2003-07-17 | — | — | WO | disclosed |
| WO-2003033653-A2 | AFFINITY ENHANCEMENT AGENTS | IMMUNOMEDICS, INC. (US) | 2003-04-24 | — | — | WO | disclosed |
| WO-1989004672-A1 | DERIVATIVES OF LINCOSAMINIDE ANTIBIOTICS | THE UPJOHN COMPANY (US) | 1989-06-01 | — | — | WO | disclosed |